Latest Tomotherapy Stories
TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it has received FDA 510(k) clearance for its TomoDirect(TM) radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the Hi-Art(R) treatment system.
PLAINSBORO, N.J., Aug.
TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it will introduce the TomoDirect(TM) discrete-angle delivery mode(1) for the TomoTherapy(R) Hi-Art(R) treatment system at two upcoming radiation oncology conferences.
Oncure Medical Corp. ("Oncure"), one of the largest operators of radiation oncology centers in the country, has purchased substantially all the assets of ROA Associates, LLP, and entered into a long-term business management agreement with Radiation Oncology Associates, P.C. (ROA) of Ft. Wayne, Ind.
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has extended its reach in Europe with the first TomoTherapy(R) Hi-Art(R) treatment system set to be installed in Scandinavia, at Lund University Hospital in Sweden.
TomoTherapy Incorporated (NASDAQ: TOMO) recently commemorated the fifth anniversary of the first patient treatment on a clinical TomoTherapy(R) Hi-Art(R) system, which occurred July 1, 2003, at Thompson Cancer Survival Center in Knoxville, Tenn.
LAKE SUCCESS, N.Y., July 10 /PRNewswire-FirstCall/ -- Two prostate cancer patients became the first people in New York to receive a faster, more comfortable form of highly accurate radiotherapy in pioneering treatments at Radiation Oncology Associates of New York (a Division of Integrated Medical Professionals, PLLC).
By Darrell Hughes, The Sun News, Myrtle Beach, S.C. Jul. 10--The Carolina Regional Cancer Center has brought to the beach a techno-savvy form of cancer treatment that aims to rid people of cancer with fewer side effects.
With the opening of the new Northern Centre for Cancer Care Newcastle is building on its international reputation for world- class cancer treatment. Back in 1948, Newcastle was identified as a premier centre in the UK for cancer care and received one of the very first radiotherapy machines.
TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy(R) Hi-Art(R) treatment system for advanced radiation therapy, today announced the close of its Treatment Quality Challenge. The company had offered $250,000 to any U.S.